Guardant Health Releases Results from ECLIPSE
Guardant Health Releases Results from ECLIPSE

https://investors.guardanthealth.com/press-releases/press-releases/2022/Guardant-Health-announces-positive-results-from-pivotal-ECLIPSE-study-evaluating-a-blood-test-for-the-detection-of-colorectal-cancer/default.aspx Last week, Guardant Health released the results of...

FDA Explores Alternatives to CDx with New Pilot Program
FDA Explores Alternatives to CDx with New Pilot Program

https://www.fiercebiotech.com/medtech/fda-looks-bypass-cancer-drugs-companion-diagnostics-new-pilot-program-pazdur FDA had begun exploring ways around the one-drug-one-test limitations of companion diagnostics by looking further into the ‘minimal performance criteria’...